Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.14365/6348| Title: | Efficacy and Safety in the KEYNOTE-966 Study of Pembrolizumab (Pembro) Plus Gemcitabine and Cisplatin (gem/cis) for Advanced Biliary Tract Cancer (BTC): Impact of Hepatitis B Virus (HBV) Infection | Authors: | Yau, T. Chan, S. L. Kelley, R. K. Finn, R. S. Yoo, C. Furuse, J. Qin, S. |
Publisher: | Elsevier | URI: | https://doi.org/10.1016/j.annonc.2024.10.169 https://hdl.handle.net/20.500.14365/6348 |
ISSN: | 0923-7534 1569-8041 |
| Appears in Collections: | WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Show full item record
CORE Recommender
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.